Given the uncertainties of the pathogenesis of lupus nephritis, the need to correlate specific histologic findings with treatment and outcomes, and the need to identify biomarkers that accurately ...

M.S., M.Ch., F.MAS Urology · 15 years of experience · India Inflammation of the kidneys that may involve the glomeruli, tubules or interstitial tissue (functional units of kidney) surrounding ...

2 Because SLE can cause diverse symptoms, which may vary over time ... one of the most dangerous manifestations of SLE: lupus nephritis (LN), characterized by immune system induced inflammation ...

It is hoped that, with years of training and practice, the nephrologist has special insight into the diagnosis and treatment of glomerulonephritis. What follows are some examples of issues of ...

Improvement in results on a noninvasive urinary biomarker panel at 3 months among patients with lupus nephritis predicted a clinical response at 1 year. A noninvasive urinary biomarker panel ...

Conventional lupus nephritis (LN) treatment based on cyclophosphamide, steroids and, recently, mycophenolatemofetil has improved the outcome of the disease over the last 50 years, although failure ...

Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

Information analyzed from a U.S. health insurance plan reveals that people with lupus nephritis (LN) are not being seen regularly enough by specialized ... 1,039 people with LN covered by the ...

The Phase 1 GALLOP study evaluating investigational therapy, CB-010, for treatment of lupus nephritis (LN) has officially started. This open label, multicenter study will assess a single infusion of ...

Our treatments include plasma therapy—also known as plasmapheresis. This clinic involves evaluation and treatment of patients with inflammation of the kidney. Untreated, glomerulonephritis can lead to ...